The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 287,193 ordinary shares in the Company, representing 0.91% of the Company’s current issued share capital.
36.31% of the issued share capital is not in public hands.
The Company is aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:
|Number of ordinary shares||% of issued share capital|
|Woodford Investment Management LLP||35.48%|
|Wales Life Sciences Investment Fund LP||9.50%|
The above information was last updated on Tuesday, 17 July 2018